BridgeBio have substantially advanced this development of an new therapy for ATTR-CM, utilizing the investigational drug. Preliminary clinical information indicates promising benefits for patients suffering with a https://bridgebio233728.newsbloger.com/42747996/firm-progresses-attr-cm-management-using-attruby